Cargando…
Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has led to a surge in clinical trials evaluating investigational and approved drugs. Retrospective analysis of drugs taken by COVID-19 inpatients provides key information on drugs associated with better or worse outcomes. METHODS: We condu...
Autores principales: | Bayat, Vafa, Ryono, Russell, Phelps, Steven, Geis, Eugene, Sedghi, Farshid, Etminani, Payam, Holodniy, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294673/ https://www.ncbi.nlm.nih.gov/pubmed/34307731 http://dx.doi.org/10.1093/ofid/ofab336 |
Ejemplares similares
-
A Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prediction Model From Standard Laboratory Tests
por: Bayat, Vafa, et al.
Publicado: (2020) -
Evaluation of Praedico™, A Next Generation Big Data
Biosurveillance Application
por: Holodniy, Mark, et al.
Publicado: (2015) -
Transmission of SARS-CoV-2 in Inpatient and Outpatient Settings in a Veterans Affairs Health Care System
por: Jinadatha, Chetan, et al.
Publicado: (2021) -
355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014) -
Predicting Inpatient Mortality Among Encephalitis Patients: A Novel Admission Risk Score
por: Hansen, Michael A, et al.
Publicado: (2020)